Article
Effects of the MAML2 genetic variants in glioma susceptibility and prognosis.
Bioscience reports - 30 Oct 2019
Zhang Ming, Zhao Yonglin, Zhao Junjie, Huang Tingqin, Guo Xiaoye, Ma Xudong, Wu Yuan
Abstract excerpt
BACKGROUND: Abnormal expression of the mastermind-like transcriptional co-activator 2 (MAML2) gene is oncogenic in several human cancers, including glioma. However, the relevance of MAML2 variants with glioma remains unknown. We aimed to investigate the role of MAML2 polymorphisms in glioma risk and prognosis among the Chinese Han population. METHODS: Seven MAML2 single-nucleotide polymorphisms (SNPs) were...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
